Read More

Reddit Shares Soar On First Post-IPO Q1 Results, Strong Q2 Guidance

Reddit reported quarterly losses of $8.19 per share which missed the analyst consensus estimate of losses $6.97 by 17.5%. Quarterly sales clocked in at $242.963 million, beating the analyst consensus estimate of $212.830 million by 14.16%. The company reported record user traffic, with Daily Active Uniques (DAUq) increasing 37% to 82.7 million and Weekly Active Uniques (WAUq) increasing 40% year-over-year to 306.2 million.

RDDT

Read More

Upstart Q1 Earnings: Revenue Beat, EPS Beat, Targeting Positive EBITDA In 2024 And More

Upstart reported first-quarter revenue of $128 million, which beat the consensus estimate of $124.867 million, according to Benzinga Pro. Upstart's top-line results were up 24% year-over-year, but down 9% sequentially. The cloud-based AI lending platform company reported an adjusted loss of 31 cents per share, which beat analyst estimates for a loss of 39 cents per share.

UPST

Read More

Nano-Cap Eledon Pharmaceuticals’ Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.

ELDN